Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge
Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge…
Endocrinology Today—March 10, 2026
This week’s Endocrinology update highlights regulatory progress in osteoporosis…
Obesity Today—March 10, 2026
This week’s Obesity update highlights regulatory approvals, emerging generic…
Endocrinology Today—March 3, 2026
This week’s Endocrinology update highlights regulatory approvals, Phase 3…
Immunology Video Recap—February 25, 2026
This biweekly Immunology video recap highlights key developments across…
Immunology Today—February 25, 2026
This week's Immunology update summarizes covering clinical-trial readouts and…
Obesity Today—February 24, 2026
This week's Obesity update highlights regulatory decisions, late-stage clinical…
Oncology Today—February 23, 2026
This week's Oncology update covers a mix of regulatory actions, filing…
Cell and Gene Therapy Video Recap—February 19, 2026
This biweekly Cell and Gene Therapy video recap covers the latest regulatory…
Cell and Gene Therapy Video Recap—February 19, 2026
This biweekly Cell and Gene Therapy video recap covers the latest regulatory…
Immunology Today—February 18, 2026
This week's Immunology update summarizes key developments in clinical trials,…
Cell and Gene Therapy Today—February 12, 2026
This week's Cell and Gene Therapy update highlights key regulatory actions,…






